Inflammation and Myocardial Infarction

被引:22
作者
Melamed, Kathryn H. [1 ]
Goldhaber, Samuel Z. [2 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Thrombosis Res Grp,Div Cardiovasc Med,Dept Med, Boston, MA 02115 USA
关键词
D O I
10.1161/CIRCULATIONAHA.114.010614
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:E334 / E336
页数:3
相关论文
共 5 条
[1]  
Libby P., Mechanisms of acute coronary syndromes and their implications for therapy, N Engl J Med, 368, pp. 2004-2013, (2013)
[2]  
Ridker P.M., Danielson E., Fonseca F.A., Genest J., Gotto A.M., Kastelein J.J., Koenig W., Libby P., Lorenzatti A.J., Macfadyen J.G., Nordestgaard B.G., Shepherd J., Willerson J.T., Glynn R.J., Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N Engl J Med., 359, pp. 2195-2207, (2008)
[3]  
Everett B.M., Pradhan A.D., Solomon D.H., Paynter N., Macfadyen J., Zaharris E., Gupta M., Clearfield M., Libby P., Hasan A.A., Glynn R.J., Ridker P.M., Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis, Am Heart J, 166, pp. 199-199e15, (2013)
[4]  
Cardiovascular Inflammation Reduction Trial Website
[5]  
North American Thrombosis Forum Website